TuHURA Biosciences (HURA) Non Operating Income (2012 - 2024)
TuHURA Biosciences (HURA) posted quarterly Non Operating Income of $48000.0 for Q3 2024, down 35.14% quarter-over-quarter from $74000.0 in Q1 2024.
TuHURA Biosciences (HURA) Non Operating Income (2012 - 2024) Analysis & Trends
TuHURA Biosciences' Non Operating Income history runs 13 years deep, the most recent figure standing at $48000.0 for Q3 2024.
- In Q3 2024, Non Operating Income changed N/A year-over-year to $48000.0; the TTM figure through Sep 2024 stood at $118000.0 (down 11.28% YoY), while the FY2024 annual figure was $131000.0, down 10.88% from the prior year.
- Non Operating Income for Q3 2024 stood at $48000.0, down from $74000.0 in the prior quarter.
- The five-year high for Non Operating Income was $74000.0 in Q1 2024, with the low at -$35000.0 in Q4 2020.
- The 5-year median for Non Operating Income is $3500.0 (2021), against an average of $9750.0.
- The sharpest annual moves came in 2021 and 2022: Non Operating Income plunged 1650.0% in 2021, then surged 2150.0% in 2022.
- TuHURA Biosciences' Non Operating Income stood at -$35000.0 in 2020, then surged by 105.71% to $2000.0 in 2021, then soared by 2150.0% to $45000.0 in 2022, then plunged by 108.89% to -$4000.0 in 2023, then surged by 1300.0% to $48000.0 in 2024.
- Business Quant data shows HURA's Non Operating Income at $48000.0 in Q3 2024, $74000.0 in Q1 2024, and -$4000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 48,000.00 |
| Mar 31, 2024 | 74,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 45,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | -35,000.00 |
| Mar 31, 2021 | -30,000.00 |
| Dec 31, 2020 | -35,000.00 |
| Sep 30, 2020 | -33,000.00 |
| Jun 30, 2020 | -2,000.00 |
| Mar 31, 2020 | 19,000.00 |
| Dec 31, 2019 | 26,000.00 |
| Sep 30, 2019 | 29,000.00 |
| Jun 30, 2019 | 316,664.00 |
| Mar 31, 2019 | 7,389.00 |